Cue Biopharma, Inc.
CUE · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$41 | -$51 | -$53 | -$44 |
| Dep. & Amort. | $2 | $3 | $2 | -$2 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $7 | $8 | $9 | $12 |
| Change in WC | -$5 | -$1 | $0 | -$4 |
| Other Non-Cash | $0 | $0 | -$0 | -$0 |
| Operating Cash Flow | -$36 | -$40 | -$42 | -$39 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$0 | $0 | -$0 | -$1 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | -$29 | $0 |
| Inv. Sales/Matur. | $0 | $25 | $5 | $10 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $0 | $25 | -$25 | $9 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$4 | -$2 | $10 | $0 |
| Stock Issued | $14 | $13 | $39 | $17 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | $4 | $2 |
| Financing Cash Flow | $10 | $12 | $54 | $19 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$26 | -$3 | -$13 | -$10 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $49 | $52 | $65 | $75 |
| End Cash | $23 | $49 | $52 | $65 |
| Free Cash Flow | -$36 | -$40 | -$42 | -$40 |